What is CoolSculpting?
CoolSculpting, established in 2009, is a medical technology company specializing in non-invasive body contouring. Its proprietary technology utilizes controlled cooling to target and eliminate unwanted fat cells, offering a less invasive alternative to traditional liposuction. The company's focus on aesthetic and wellness solutions positions it within a growing market driven by consumer demand for effective, non-surgical procedures.
The company's commitment to innovation in aesthetic medicine has been a key driver of its market presence.
How much funding has CoolSculpting raised?
CoolSculpting has raised a total of $136.3M across 3 funding rounds:
Series B
$20.3M
Series D
$25M
Stock Offering
$91M
Series B (2009): $20.3M with participation from Frazier Healthcare Ventures and Advanced Technology Ventures
Series D (2010): $25M led by Frazier Healthcare Ventures, Venrock, and Advanced Technology Ventures
Stock Issuance/Offering (2011): $91M, investors not publicly disclosed
Key Investors in CoolSculpting
Frazier Healthcare Ventures
Frazier Healthcare Ventures is a venture capital firm with a focus on the healthcare sector, likely investing in companies with innovative medical technologies and therapeutic solutions.
Advanced Technology Ventures
Advanced Technology Ventures (ATV) is a seasoned venture capital firm with a broad investment thesis across technology markets, including healthcare, suggesting a strategic interest in CoolSculpting's technological advancements.
Venrock
Venrock is a well-established venture capital firm known for backing innovative companies in technology and healthcare, indicating a strategic alignment with CoolSculpting's market position and growth potential.
What's next for CoolSculpting?
The substantial enterprise-level funding and recent strategic investment indicate CoolSculpting is poised for significant expansion. This capital is likely to fuel further research and development into new treatment modalities, enhance manufacturing capabilities, and broaden its global market reach. The company's trajectory suggests a focus on solidifying its leadership in the body contouring market and potentially exploring adjacent aesthetic and wellness sectors.
Strategic partnerships and continued technological advancements will be crucial for maintaining its competitive edge and capitalizing on emerging market opportunities.
